Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Nobiletin is a polymethoxylated flavone found predominantly in citrus peels, especially tangerines. Recent preclinical studies have provided scientific support for its potential role in addressing metabolic syndrome, a cluster of conditions including obesity, dyslipidemia, insulin resistance, and hypertension. Animal studies have shown that nobiletin can improve glucose tolerance, reduce hepatic steatosis, and lower plasma triglyceride and cholesterol levels. Mechanistically, nobiletin appears to enhance insulin sensitivity, activate AMPK (AMP-activated protein kinase), and modulate circadian rhythm genes that are involved in lipid and glucose metabolism. For instance, a 2013 study published in Cell Metabolism demonstrated that nobiletin supplementation in mice fed a high-fat diet led to significant improvements in metabolic parameters and prevention of obesity. However, while the preclinical evidence is promising, human clinical trials are limited. A few small-scale studies suggest potential metabolic benefits, but robust, large-scale human data are lacking. Thus, while there is a scientific rationale and encouraging animal data, the evidence for nobiletin's use in metabolic syndrome in humans remains preliminary. Continued research, particularly well-controlled clinical trials, is needed to fully establish its efficacy and safety profile for this indication.

More about Nobiletin
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Nobiletin

Products containing Nobiletin